Abstract:Background:Hypermethylated in Cancer 1 (HIC1) was originally confirmed as a tumor suppressor and has been found to be hypermethylated in human cancers. Although growing evidence has supported the critical roles of HIC1 in cancer initiation and development, its roles in tumor immune microenvironment and immunotherapy are still unclear, and no comprehensive pan-cancer analysis of HIC1 has been conducted.Methods:HIC1 expression in pan-cancer, and differential HIC1 expression between tumor and normal samples were investigated. Immunohistochemistry (IHC) was employed to validate HIC1 expression in different cancers by our clinical cohorts, including lung cancer, sarcoma (SARC), breast cancer, and kidney renal clear cell carcinoma (KIRC). The prognostic value of HIC1 was illustrated by Kaplan-Meier curves and univariate Cox analysis, followed by the genetic alteration analysis of HIC1 in pan-cancer. Gene Set Enrichment Analysis (GSEA) was conducted to illustrate the signaling pathways and biological functions of HIC1. The correlations between HIC1 and tumor mutation burden (TMB), microsatellite instability (MSI), and the immunotherapy efficacy of PD-1/PD-L1 inhibitors were analyzed by Spearman correlation analysis. Drug sensitivity analysis of HIC1 was performed by extracting data from the CellMiner™ database.Results:HIC1 expression was abnormally expressed in most cancers, and remarkable associations between HIC1 expression and prognostic outcomes of patients in pan-cancer were detected. HIC1 was significantly correlated with T cells, macrophages, and mast cell infiltration in different cancers. Moreover, GSEA revealed that HIC1 was significantly involved in immune-related biological functions and signaling pathways. There was a close relationship of HIC1 with TMB and MSI in different cancers. Furthermore, the most exciting finding was that HIC1 expression was significantly correlated with the response to PD-1/PD-L1 inhibitors in cancer treatment. We also found that HIC1 was significantly correlated with the sensitivity of several anti-cancer drugs, such as axitinib, batracylin, and nelarabine. Finally, our clinical cohorts further validated the expression pattern of HIC1 in cancers.Conclusions:Our investigation provided an integrative understanding of the clinicopathological significance and functional roles of HIC1 in pan-cancer. Our findings suggested that HIC1 can function as a potential biomarker for predicting the prognosis, immunotherapy efficacy, and drug sensitivity with immunological activity in cancers.

The comprehensive landscape of prognosis, immunity, and function of the GLI family by pan-cancer and single-cell analysis

Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors

Comprehensive Analysis of the Role of Hedgehog Signaling and Prognostic Significance in Human Pancreatic Cancer

Glioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation

Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy

Combinatorial Gli Activity Directs Immune Infiltration and Tumor Growth in Pancreatic Cancer.

Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India

Abstract B035: Investigating the roles of GLI transcription factors in the pancreatic cancer microenvironment

Characterization of SHCBP1 to Prognosis and Immunological Landscape in Pan-Cancer: Novel Insights to Biomarker and Therapeutic Targets.

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer

Identification of Hedgehog Signaling As a Potential Oncogenic Driver in an Aggressive Subclass of Human Hepatocellular Carcinoma: A Reanalysis of the TCGA Cohort.

Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome

Expression and clinical significance of hedgehog signaling pathway related components in colorectal cancer.

Bioinformatics analysis of hedgehog interacting protein in colorectal cancer: a study based on GEO data and TCGA data

Ferroptosis-related Gene HIC1 in the Prediction of the Prognosis and Immunotherapeutic Efficacy with Immunological Activity.

A pan-cancer analysis of the expression and prognostic significance of PDRG1

Elucidating Hedgehog Pathway's Role in HNSCC Progression: Insights from a 6-Gene Signature

GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression

Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator

Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis

Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma